Photocrosslinkable materials have been frequently used for constructing soft and biomimetic hydrogels for tissue engineering. Although, ultraviolet (UV) light is commonly used for photocrosslinking such materials, its use has been associated with several biosafety concerns such as DNA damage, accelerated aging of tissues, and cancer. Here we report an injectable visible light crosslinked gelatin-based hydrogel for myocardium regeneration. Mechanical characterization revealed that the compressive moduli of the engineered hydrogels could be tuned in the range of 5-56 kPa, by changing the concentrations of the co-initiator and co-monomer in the precursor formulation. In addition, the average pore sizes (26-103 μm) and swelling ratio (7-13%) were also shown to be tunable by varying the hydrogel formulation. In vitro studies showed that visible light crosslinked GelMA hydrogels supported the growth and function of primary cardiomyocytes (CMs).
Introduction
Hydrogels have been widely used for tissue engineering and regenerative medicine as artificial scaffolds, mimicking the extracellular matrix (ECM) surrounding the cells 1 . Their high water content, tunable chemical and physical properties, and ability to encapsulate cells, bio-macromolecules (e.g., peptides/proteins, nucleotides, antibodies), and therapeutic agents open a variety of potential applications [1] [2] [3] [4] . In particular, biopolymers that allow in-situ sol-gel transition could be used to develop injectable materials, which can be delivered locally in a minimally invasive and cost-effective manner 5 . Injectable hydrogels made of natural or synthetic polymers have been widely reported, and have been shown to exhibit both advantages and drawbacks 5, 6 . For instance, natural polysaccharide-based hydrogels such as hyaluronic acid, chitosan, alginate, and chondroitin sulfate have been extensively used due to their biocompatibility and biodegradability, but are limited by their low mechanical properties, as well as difficulties in tuning their degradation rate and biological functions 4, 6 . On the other hand, synthetic polymer-based hydrogels such as poly(ethylene glycol) (PEG) and poly(vinyl alcohol) (PVA) have high mechanical strength with tunable microstructure, but often suffer from the lack of biological moieties 4, 6 . Thus, there is a need for the development of hydrogels that can combine the advantages of both natural and synthetic polymers 7 .
Light-induced photocrosslinking has been widely used for the fabrication of cell-laden injectable hydrogels with rapid gelation time and tunable physical properties 8 . Ultraviolet (UV) light is commonly used for photocrosslinking of such materials, as well as commercial products for dental applications. We have recently reported the engineering of highly elastic hydrogels via UV light-mediated crosslinking of chemically modified tropoelastin or elastin-like polypeptides for wound healing and cardiac tissue engineering [9] [10] [11] [12] . These UV crosslinked hydrogels exhibited high cytocompatibility for Please do not adjust margins Please do not adjust margins three-dimensional (3D) encapsulated cells in vitro, as well as a negligible immune responses after subcutaneous implantation in rats 13 . In addition, UV crosslinked gelatin methacryloyl (GelMA)-based hydrogels have been used as 3D cell-laden hydrogels to promote in vitro vascularization and tissue formation [14] [15] [16] . Although, we have shown that injection of cellladen GelMA hydrogels in rats led to vascular network formation and tissue healing 17 , in situ UV crosslinking of GelMA prepolymer may negatively impact the normal function of sensitive tissues such as the myocardium. The clinical translation of UV crosslinkable hydrogels as injectable materials for soft tissue regeneration has been limited due to the biosafety concerns associated with the use of UV light. UV light may generate reactive oxygen species (ROS), which may induce endogenous oxidative damage to DNA (e. g., dimerization or hydroxylation of bases) and cause accelerated tissue aging or cancer 18 . Other studies have reported that oxidative DNA alterations could be induced by UV (i.e., 337 nm) 19 , and that DNA damage was dramatically decreased above 470 nm 20 . Furthermore, recent studies have demonstrated that UV light could directly induce alterations in the DNA, and lead to immunosuppression in vivo 21, 22 . In another study, Federovich et al. demonstrated that the combination of both UV light and the photoinitiator Irgacure 2959 resulted in harmful effects on cell viability 23 . However, it was shown that the photopolymerization process in the presence of hydrogel precursors led to higher cell viability. This observation suggested that free radicals generated during photopolymerization were consumed during the crosslinking process, reducing the damage to cellular components 23 . These studies together demonstrated that the development of hydrogels that utilize visible light, with safer photoinitiators as the energy source for the crosslinking reaction, can enhance the utility of photocrosslinkable hydrogels for tissue engineering applications. Additionally, visible light has been shown to penetrate tissues at higher depths and with lower energy, as compared to UV light 24 . This characteristic makes visible light suitable for developing in situ injectable materials, for minimally invasive procedures.
Eosin Y is a Food and Drug Administration (FDA)-approved photoinitiator excited by visible light (450 -550 nm) ( Figure  1a-b) , which was used in the photocrosslinkable lung sealant FocalSeal® (Genzyme Biosurgical, Cambridge, MA). Eosin Y has been used in many thiol-ene crosslinking reactions to fabricate hydrogel-coated surfaces 25 , mesenchymal stem cell-laden hydrogels 26 , and growth factor delivery systems 27 . Other photoinitiators such as camphorquinone, fluorescein, and riboflavin have also been used to initiate photocrosslinking upon exposure to blue light 18 . However, the use of prolonged irradiation to obtain hydrogels with appropriate mechanical strength with these photoinitiators may lead to toxic effects on the encapsulated cells, when using them as cell-laden injectable hydrogels 28 .
Several groups have reported the application of injectable hydrogels for cardiac tissue regeneration. For example, an extracellular matrix (ECM)-derived hydrogel was used as an injectable material for the treatment of infarcted myocardial tissue 29 . The injection of this hydrogel into infarcted pig hearts led to increased cell infiltration due to tissue self-assembling into the porous scaffold. In addition, histological analysis showed that a layer of endocardium was developed due to injection of the hydrogel 29 . Other studies reported the use of UV light crosslinkable hydrogels for the repair of anterolateral cardiac incisions. These results showed an increase in wall thickness of the left ventricle, which enhanced the survival of both viable and infarcted cardiac tissues [30] [31] [32] .
Here, we report the synthesis of a gelatin-based injectable hydrogel for myocardial repair via visible-light-initiated photocrosslinking, using Eosin Y as a photoinitiator, Triethanolamine (TEA) as a co-initiator and N-vinylcaprolactam (VC) as a co-monomer. The GelMA prepolymer solution was photopolymerized upon exposure to visible light to form hydrogels with tunable physical properties. We evaluated the mechanical properties, porosity, and swelling behavior of the engineered hydrogels, as well as their in vitro and in vivo biocompatibility. We also investigated the feasibility of hydrogel delivery to infarcted hearts in vivo. It is hypothesized that the engineered material can be used as a safe and fast polymerizable hydrogel with controlled physical properties. In addition, they could also be used for the repair of a variety of soft tissues such as heart, blood vessels, and skin, and may facilitate the clinical translation of injectable hydrogels for soft tissue regeneration.
Results and Discussion
In this study, we engineered injectable visible light crosslinked GelMA hydrogels for cardiac tissue repair. These hydrogels were formed by the photochemical reaction of methacryloyl units, available on GelMA chains and activated by Eosin Y, which absorbs light between 450 to 550 nm (Figure 1a -b) 1, 3 . Photocrosslinking via UV light (250 nm < λ < 400 nm) relies on the use of photoinitiators such as Irgacure 2959 26, 27 . However, alternative photoinitiators such as VA-086, that absorb safer UV ranges (≈405 nm) than Irgacure 2959 and lead to enhanced cytocompatibility have been recently described 33 . UV light photons cause dissociation of the photoinitiator into two radicals, which cause radical formation on the methacryloyl groups. Since radicals are unstable entities, they quickly combine with each other in their vicinity, leading to a crosslinked network. An alternative to UV photoinitiation is using Eosin Y in combination with visible light (400 nm < λ < 700 nm). Visible light excites Eosin Y from the ground state into a triplet state. This then extracts hydrogen atoms from amine-functionalized co-initiators, such as TEA. The deprotonated TEA radical then initiates the formation of a radical center on the methacryloyl groups of GelMA. Visible light mediated polymerization often requires co-monomers, such as VC, to generate an adequate number of radicals to accelerate the gelation process (Figure 1 ) 34 . This increased gelation rate in the presence of VC could be due to an increased vinyl group concentration, and/or rapid diffusion of radical bearing VC 26 . In addition, photoinitiation via Eosin Y could be visually confirmed by a change in color from red to yellow, which occurs after the formation of activated Eosin Y (Figure 1c ).
It has been reported that in an ideal and fully crosslinked hydrogel network with a certain prepolymer molecular weight and functionality, the crosslinking density of the hydrogel should not be affected by the photoinitiator and co-initiator concentrations 35 . Therefore, the physical properties of the hydrogel, such as pore characteristics, swelling ratios, and mechanical properties should also remain constant. However, in a visible light system, which is based on free radical chain reaction polymerization, an ideal fully crosslinked hydrogel network cannot be obtained due to the presence of unreacted functionalities, dangling polymers, and primary cycles 35 . This behavior is particularly observed at lower prepolymer or initiator concentrations 36 . Therefore, in our system, since the hydrogel network was not fully crosslinked even after 180 sec light exposure time, the physical properties of the engineered hydrogels were dependent on TEA, Eosin Y, and VC concentrations.
Previous studies have investigated the effects of photoinitiator and co-initiator concentrations on the physical properties of visible light crosslinked hydrogels 25, 26, 36, 37 37 . Their results demonstrated that the dynamic modulus of the resulting PEGDA hydrogels ranged from 25 to 125 kPa at 120 sec light exposure time 37 . In another study, Shih et al. also showed that by increasing the Eosin Y concentration from 0.1 to 2.0 mM, the swelling ratio of a visible light crosslinked PEG-based hydrogel increased approximately 2 fold at 240 sec light exposure time 25 . Here, we investigated the effects of these variables on the physical properties (i.e., porosity and swellability) of the engineered GelMA hydrogels (Figure 2 ). The porosity of a hydrogel is key for its interaction with cells and the surrounding tissues 2, [38] [39] [40] . The modulation of the micro-architectural properties and the porosity of a hydrogel could be used to deliver bioactive cues to cells growing within the engineered constructs 2, 39 . Additionally, increased porosity promotes cellular penetration and new tissue formation within the 3D structure of the hydrogels 2 . For these experiments, we used a fixed concentration of 0.1 mM Eosin Y. Eosin Y regenerates during light exposure, whereas TEA radicals and VC are consumed by the crosslinking of GelMA, as shown in Figure 1a . Therefore, we anticipated that the swelling ratio and pore size are more dependent on the concentration of TEA and VC than Eosin Y. Our results demonstrated that the apparent pore size in the center area of GelMA hydrogels decreased from 77.1 ± 9.9 μm to 41.0 ± 8.4 μm and 25.6 ± 5.5 μm as the VC concentration increased from 0.5 %(w/v) to 1 %(w/v) and 1.5 %(w/v), respectively, for hydrogels with 10 %(w/v) GelMA, 1 %(w/v) TEA, and 0.1 mM Eosin Y (Figure 2a-c, g ). We also investigated the changes in hydrogel porosity by varying the concentration of TEA ( Figure S1 , 2h). However, we did not observe any statistically significant differences in pore size between different TEA concentrations. Similarly, the pore sizes on the surface of the hydrogels could also be tuned by varying the concentration of VC (Figure 2g ). It is important to note that the apparent porosity of the hydrogel could be due to lyophilization of the hydrogels prior to SEM analysis. Previous studies have shown that the pore size of hydrogels could be affected by the freezing temperature before lyophilization 2 . In our study, all samples were processed following a methodology reported previously to compare the average pore size through SEM analysis, using different formulations of UV crosslinked GelMA hydrogels 15 . In general, GelMA hydrogels crosslinked via visible light showed a pore size distribution similar to that of UV crosslinked GelMA hydrogels. The effects of VC and TEA concentrations on the maximum swelling ratio of the engineered hydrogels were also investigated (Figure 2i-j). As shown in Figure 2i , the swelling ratio decreased significantly from 8.2 ± 0.36 % to 6.9 ± 0.55 % when the concentration of VC increased from 1.0 %(w/v) to 1.5 %(w/v). In addition, increasing TEA concentrations from 0.5 %(w/v) to 1.0 %(w/v), and 1.5 %(w/v) reduced the swelling ratios from 13.4 ± 1 % to 8.2 ± 0.3 % and 7.1 ± 0.4 %, respectively ( Figure  2j ). For all these hydrogels, 10 %(w/v) GelMA and 0.1 mM Eosin Y were used. These results suggested that lowering the concentration of the co-initiator and the co-monomer may also lower the crosslinking density and lead to higher swelling capacity.
The mechanical properties of photocrosslinked GelMA hydrogels were also tuned by changing the concentrations of TEA and VC ( Figure 3 ). Our results showed that GelMA hydrogels exhibited tunable compressive moduli in the range of 5 -56.5 kPa, and tensile moduli ranging from 5 to 22.7 kPa, depending on the VC, TEA, and Eosin Y concentrations ( Figure  3 ). The compressive moduli of 10 %(w/v) GelMA hydrogels, formed by using 1.0 %(w/v) TEA, and 0.1 mM Eosin Y decreased from 26.9 ± 9.9 kPa to 17.2 ± 5.7 kPa and 10.3 ± 5.2 kPa when the VC concentrations were lowered from 1.5 %(w/v) to 1 %(w/v) and 0.5 %(w/v), respectively (Figure 3a-c). In addition, the tensile moduli of the hydrogels decreased from 15.1 ± 4.0 kPa to 12.9 ± 1.7 kPa and 6.3 ± 0.6 kPa as the VC concentrations were lowered from 1.5 %(w/v) to 1 %(w/v) and 0.5 %(w/v), respectively, at a constant 1.0 %(w/v) TEA and 0.1 mM Eosin Y concentration (Figure 3d -f). Increasing VC and TEA concentrations influences the dynamics of the reaction and thus, the number of crosslinking sites may increase at a constant light exposure time (i.e., 180 sec). This enhanced crosslinking density may result in an increase in hydrogel stiffness, as well as a decrease in the swelling ratio and pore sizes 34 . These results are in agreement with our previous work based on engineering UV light crosslinked GelMA and methacryloyl-substituted tropoelastin (MeTro) hydrogels 9, 15 . In this study, the mechanical properties of the hydrogels were dependent on the prepolymer and initiator concentrations, as well as light exposure time. We also investigated the effect of varying the concentration of Eosin Y on the mechanical properties of the engineered GelMA hydrogels. Our results showed that the highest compressive modulus was obtained at 0.1 mM Eosin Y for 10 % GelMA hydrogels with 1 %(w/v) VC and 1 %(w/v) TEA ( Figure S2 ). The mechanical properties of the engineered GelMA hydrogels (6-56.5 kPa) in this study were in the range of those reported previously for UV crosslinked GelMA hydrogels (5-50 kPa) 15 . In addition, the mechanical strength was comparable to that of native heart tissue (i.e., Young's modulus: 10-50 kPa) 41, 42 . These observations suggest that GelMA hydrogels should integrate well with native tissue, without causing failure due to the mechanical mismatch. Based on the mechanical characterization, the optimized hydrogel formulation of 10 %(w/v) GelMA, 1.5 %(w/v) TEA, 1 Please do not adjust margins Please do not adjust margins %(w/v) VC and 0.1 mM Eosin Y was used for all in vitro, ex vivo and in vivo experiments. In particular, the light exposure time (i.e., 180 sec) for hydrogels with 1 mm thickness synthesized for mechanical characterization, ex vivo and in vivo experiments, was lowered to 20 sec for the 150 μm-thick hydrogels used for in vitro experiments.
Engineering cardiac tissue constructs requires a matrix/scaffold for maintenance of cell viability, organization, and tissue formation 27 . Therefore, we investigated the suitability of the engineered visible light crosslinked GelMA hydrogel as a matrix to support cardiomyocyte (CM) growth. We first investigated the in vitro cytocompatibility of GelMA hydrogels using surface seeding (2D, Figure S3a These results demonstrated that visible light crosslinked hydrogels could efficiently support the growth, spread, and proliferation of NIH 3T3 fibroblasts grown in both 2D and 3D cultures. We then evaluated the ability of the engineered GelMA hydrogels to support the growth and contractile function of primary rat CMs in vitro. We have previously shown that UV crosslinked GelMA hydrogels could be used to engineer cardiac tissue constructs 11, 43 . Although these GelMA-based hydrogels were shown to support the growth of CM in vitro, direct in vivo delivery could potentially impair cardiac function due to tissue damage caused by UV light. Therefore, we aimed to address this limitation by using visible light to form a highly biocompatible cell-laden hydrogel that could preserve the contractile function of CMs. For these experiments, we also used a live/dead assay and DAPI/F-actin staining to evaluate cell viability (Figure 4a Figure 4h ). However, this observation could be due to the proliferation of cardiac fibroblasts that could not be removed after CM isolation.
Previous studies have demonstrated that CMs maintained in conventional 2D culture conditions tend to regress to a less mature phenotype, and lose the ability to respond to physiological stimuli 44, 45 . Thus, we also investigated the ability of GelMA hydrogels to maintain the phenotype of primary rat CMs in vitro. First, we evaluated the expression of the CM marker sarcomeric α-actinin (SAA), using 2D cultures of primary CMs on GelMA hydrogels. Our results showed positive immunolocalization of SAA in CMs maintained on the engineered GelMA hydrogels after 7 days of culture (Figure 4i ). In addition, fluorescent images showed that cells exhibited well-defined, cross-striated sarcomeric structures, which resembled those of native rat ventricular myocardium 46 ( Figure 4i ). Lastly, we evaluated the ability of visible light crosslinked GelMA hydrogels to support the contractile function of primary CMs growing on 2D cultures. These results showed that CMs exhibited synchronous contractions, when cultured on the surface of GelMA hydrogels (Supporting Information, Videos 1, 2). The beating frequency of CMs was quantified up to 10 days after seeding, and was shown to vary from 18-77 beats min -1 (Figure 4j) . Furthermore, the metabolic activity of cardiac cells on 2D cultures increased significantly at day 5 post seeding, as shown by a commercial PrestoBlue assay (Figure 4k ). Taken together, these results demonstrated that visible light crosslinked GelMA hydrogels could be used to support the growth and preserve the contractile function and phenotype of primary CMs in vitro.
We then performed ex vivo tests to investigate the injectability of GelMA hydrogels, and the ability to photopolymerize the gel with visible light following injection into the myocardium ( Figure 5 ). For this, 200 μL of GelMA prepolymer (10% (w/v)) were injected into the right ventricle of an excised, adult Sprague-Dawley rat heart, followed by 180 sec of exposure to visible light, at a distance of 1 cm. The presence of the photocrosslinked hydrogels within the explanted tissue was verified via immunofluorescent staining (nuclei -DAPI, α-smooth muscle actin (αSMA) -TRITC) of cryosectioned right ventricular tissue. Due to the strong auto-fluorescence of Eosin Y 47, 48 , the engineered hydrogels appeared as large green fluorescent areas devoid of nuclear staining, which suggested that GelMA was successfully injected into the myocardium and photocrosslinked in situ (Figure 5a-d) . In addition to the lack of cellularity, the structure and morphology of the injected GelMA is vastly different from healthy tissue (Figure 5a-d) . Furthermore, the positive green fluorescence within the αSMA positive vascular structures suggested that GelMA was crosslinked within the blood vessels (Figure 5c ). However, this was mainly because the injection was performed ex vivo, where the absence of blood flow allowed for the infiltration of small amounts of hydrogel precursor into the vasculature. The presence of GelMA hydrogel within the ventricular wall was further confirmed through H&E staining of tissue cryosections following ex vivo injection (Figure 5e-h) . Histological assessment revealed acellular regions with increased matrix density, as compared to the surrounding healthy myocardium (Figure 5e-h) . These results confirmed that visible light crosslinked GelMA materials can be injected and photocrosslinked in situ, demonstrating their suitability for cardiac tissue engineering applications.
Next, we aimed to investigate the regenerative potential and in vivo injectability of visible light crosslinked GelMA hydrogels, using a myocardial infarction (MI) model. MI was induced in 8-week old Sprague-Dawley rats via permanent ligation of the coronary artery. Next, 50 μL of prepolymer solution (10% (w/v)) were injected into 4 areas (200 µL total) within the infarcted region of the left ventricle, followed by photocrosslinking by exposure to visible light for 180 sec, at a distance of 1 cm (Figure 6a,b) . Animals receiving saline injections (sham) were used as controls (Figure 6c,e) . The efficient delivery of GelMA hydrogels in vivo following MI Please do not adjust margins
Please do not adjust margins demonstrated the feasibility for injection and in situ gelation during open-heart surgeries (Figure 6d,f) . Crosslinked GelMA was visible from the epicardial surface ( Figure 6d ) and was also visible as a change in ECM density in Masson's trichrome images of hearts isolated immediately post-injection ( Figure  6f ). Animals were sacrificed 3 weeks after MI, and cardiac tissues were harvested and processed for histological assessment. As expected, the scar tissue on the free wall from the left ventricles of animals with MI became thin and collagenous, with little histological differences among the infarcted groups, as demonstrated by Masson's trichrome staining (Figure 6g-i) .
Differences were apparent with GelMA treatment in the immunofluorescent staining of the infarct region of the hearts. Due to the permanent ligation of the left coronary artery, significant decreases in cardiac α-actin (CAA) + CMs were observed in the left ventricle of the sham and GelMA treated animals after 3 weeks (Figure 6 j-m) . However, low numbers of CAA + CMs and von Willebrand Factor (vWF) + endothelial cells were identified on the inner region of the scar area in GelMA treated animals (Figure 6l,m) . This observation suggested that the GelMA injection may alter the rate of remodeling of the damaged tissue, given that the sham did not show any positive staining for SAA. In addition, positive staining for vWF was only observed in the endothelium lining the inner ventricular surface (Figure 6k) . Typically, the infarct region becomes inundated with activated cardiac fibroblasts (also called myofibroblasts), which are defined by expression of αSMA. The reduction in αSMA + cells within the GelMA treated scar region, as compared to the sham scar region, suggested a reduction in myofibroblast activation, 3 weeks after MI ( Figure  6 n,o). αSMA expression in GelMA treated tissues more closely resembles that of healthy tissues, with no positive αSMA staining outside of the vessel linings. In addition, our results also showed the maintenance of larger vessels normally present in healthy tissue, as opposed to smaller neo-vessels present in the remodeled infarcted region in control (sham) animals ( Figure 6 n-p) . Therefore, the delivery of GelMA hydrogels appeared to enhance CM viability, which might be due to the modulation of the remodeling response of the tissue (evidenced by reduced αSMA+ fibroblasts), as well as the maintenance of larger vessels in the infarcted region (Figure 6 p) . However, further studies are necessary to fully determine the exact nature of these effects. Previous studies have demonstrated that upon MI, cardiac stem cells (CSCs) migrate to the site of injury and participate in the repair of the injured tissue 49, 50 . In addition, we have also demonstrated previously that UV crosslinked GelMA-based hydrogels could support capillary formation in vivo after implantation 14 and after injection 51 . Therefore, GelMA hydrogels could potentially be used to support homing and attachment of migratory CSCs and to promote vascularization in vivo, which would potentially promote regeneration after MI.
In summary, we demonstrated the ability to photocrosslink GelMA hydrogels in situ using visible light, following intra myocardial delivery. In vivo studies following MI confirmed that the delivery of photocrosslinkable GelMA hydrogels appears to be safe and feasible. However, more comprehensive experiments should be undertaken to optimize the delivery of the hydrogels and to assess the potential benefits of GelMA hydrogels for improving cardiac function after MI.
Conclusion
Here, we developed visible light crosslinked GelMA hydrogels with tunable physical properties. The use of visible light may help circumvent the potential biosafety concerns associated with the use of toxic initiators or UV light. The physical properties of the engineered hydrogels (i.e., mechanics, swelling behavior, and porosity) could be modulated by varying the concentrations of the photoinitiators in the hydrogel precursor solution. For example, the compressive modulus could be tuned in the range of 5-56.5 kPa, making it a suitable candidate for soft tissue engineering applications. In addition, the engineered hydrogels were shown to be cytocompatible, both in vitro and in vivo. The safe delivery and in situ polymerization of visible light crosslinked GelMA hydrogels make them remarkably suitable for tissue engineering applications and lithography-based platforms, where the use of UV light may potentially affect biological functions.
Experimental
Synthesis of methacryloyl gelatin (GelMA): GelMA was synthesized as described previously 15 . Briefly, 10 g of gelatin (Sigma-Aldrich, from porcine skin) was dissolved in 100 mL of Dulbecco's phosphate buffered saline (DPBS) (Gibco®) at 50 °C. 8 mL of methacrylic anhydride (MA, Sigma-Aldrich) was slowly added dropwise to the gelatin solution at 50 °C under vigorous stirring, and then the mixture was kept for 3 h at 50 °C. After a two-fold dilution with DPBS (pre-warmed at 50 °C), the solution was dialyzed against distilled water by using a dialysis membrane (Spectrum® Laboratories, MWCO = 12-14 kDa) for 7 days at 40 °C, followed by lyophilization. 
Preparation of

Swelling ratio measurement:
The equilibrium swelling ratios of GelMA hydrogels were determined at 37 °C in DPBS. GelMA Please do not adjust margins Please do not adjust margins hydrogels for evaluating swelling behavior was prepared in a cylinder-shaped polydimethylsiloxane (PDMS) mold (7 mm in diameter, 1 mm in depth). 80 μL of precursor solution were exposed to blue-green light for 180 sec, at a distance of 1 cm, in a mold covered by a glass coverslip. Formed hydrogels were removed from the mold and detached from glass coverslip, followed by washing with DPBS for 5 min. The samples were lyophilized, and then their weights in dried state were measured. Their mass values were measured again after incubating in DPBS for 24 h. The swelling ratio was defined as the ratio of the mass value after swelling to the mass value of dried samples after lyophilization.
Scanning Electron Microscope (SEM) analysis: SEM analysis was performed to evaluate the porosity of the crosslinked hydrogels. Samples were frozen at -70 °C overnight, and then dried under vacuum overnight. Lyophilized samples were prepared as described above for swelling ratio measurements. SEM images were obtained by using a FEI/Phillips XL30 FEG SEM (15 kV), and lyophilized gels were coated by gold prior to analysis. The pore sizes of GelMA gels were averaged from at least 3 images from 3 samples for each condition (n=100).
Mechanical characterization:
Tensile and compressive strength of GelMA hydrogels were measured by using an Instron 5542 mechanical testing machine with a 10 N load cell. For compression tests, GelMA hydrogels were prepared in the same way described above for swelling ratio measurements. After light exposure, the crosslinked hydrogels were incubated in DPBS for 1 h, and then the size of swollen gels was measured using a digital caliper l (Diameter: 7.5 ± 0.12 mm, Thickness: 1.5 ± 0.10 mm) prior to testing. Compression tests were performed at 1 mm/min speed until failure. The compressive modulus was calculated as the tangent slope of the linear region (0% to 5% strain) of the stress-strain curves. For tensile tests, hydrogels were prepared in rectangular molds (Length: 8.9 ± 0.13 mm, Thickness: 1.7 ± 0.10 mm, and Width: 4.6 ± 0.15 mm). The hydrogels were allowed to swell for 1 h in DPBS before measurement. Then, both edges of the hydrogels were attached to fine adhesive tapes and placed on the grips of the machine. The measurement was performed at 2 mm/min speed until failure occurred. The elastic modulus was calculated as the tangent slope of the linear region (0% to 5% strain) of the stress/strain curves. Three samples were tested for each condition.
Cell isolation and culture: Primary rat CMs were isolated from 2-day-old neonatal Sprague-Dawley rats following the protocol approved by the Institute's Committee on Animal Care. Briefly, Sprague-Dawley neonatal pups were transferred into a clean cage and narcosis was induced using compressed CO 2 . The pups were quickly decapitated with scissors after disinfecting the neck and sternum with 70 % ethanol. The thorax was then opened through a straight line on the sternum to excise the heart. The isolated hearts were placed in cold Hank's Balanced Salt Solution (HBSS) buffer, before removing the atria and blood vessels. Each heart was quartered and incubated in a solution of trypsin (0.06 %(w/v)) in HBSS at 4 °C for 16 h on a shaker. Trypsin digestion was then stopped by adding culture media, followed by shaking for 5 min at 37 °C. The tissues were then serially digested in collagenase type II solution (0.1 %(w/v)) in HBSS (10 min incubation with shaking at 37 °C for each digestion). The supernatant from the first digestion was discarded, and the cell suspensions from the subsequent second to third digestions were centrifuged at 1000 rpm for 5 min. Cells were then re-suspended in DMEM containing 10 % FBS and 2 mM Lglutamine. The cell suspension was transferred to a T-175 flask and incubated for 1 h to enrich for CMs (cardiac fibroblasts were attached to the flask, while CMs remained in suspension). Each hydrogel was then seeded with 7.5 ×10 5 cells in a 24 well plate immediately after pre-plating and cultured in DMEM media containing FBS (10 %), L-glutamine (1 %, Gibco®), and penicillinstreptomycin (100 units ml -1 ) for up to 14 days. NIH 3T3 fibroblasts were cultured in DMEM media with 10 % of FBS and 1 % of penicillin-streptomycin. Cells were passaged approximately 2-3 times per week, and culture media was changed every 2 days.
Surface seeding (2D culture): Hydrogel precursors (10 μL) were exposed to blue-green light for 20 sec, at a distance of 1 cm, covered by a glass slide coated by 3-(trimethoxysilyl) propyl methacrylate (TMSPMA, Sigma-Aldrich) and confined in 150 μm spacers. NIH 3T3 cells (5 × 10 4 cells/scaffold) and CMs (7.5 × 10 5 cells/scaffold) were seeded on top of the hydrogels attached to the TMSPMA-treated glass slides. UV light crosslinked GelMA hydrogels were synthesized by using 0.5 %(w/v) Irgacure 2959 as photoinitiator and 20 sec light exposure (6.9 mW/cm 2 ).
Cell encapsulation (3D culture): NIH 3T3 cells were trypsinized and re-suspended (5 × 10 6 cells/mL) in the hydrogel precursor before light exposure. Cell-laden GelMA hydrogels (10 μL) were formed by exposure to blue-green light for 20 sec, at a distance of 1 cm, and bound to TMSPMA-coated glass slides. The formed cell-laden gels were washed 3 times with DPBS and incubated in culture medium at 37 °C.
Cell viability:
The viability of cells was measured using a LIVE/DEAD® Viability/Cytotoxicity kit for mammalian cells (Invitrogen™) according to instructions from the manufacturer. Briefly, cells were stained with 0.5 μL/mL of calcein AM and 2 μL/mL of ethidium homodimer-1 (EthD-1) in DPBS for 15 min at 37 °C in the culture incubator. The stained cells (green for live cells, red for dead cells) were imaged using an inverted fluorescence microscope (Zeiss Axio Observer Z1) after 1, 4, and 7 days post-seeding. The number of live and dead cells was quantified using the ImageJ software, and the viability was determined by the number of live cells divided by the total number of live and dead cells. Three samples were used per condition and three images were obtained from each sample to quantify cell viability.
Cell adhesion, proliferation and spreading: Cells were stained with Rhodamine-phalloidin (Alexa-fluor 488-labeled or 594-labeled, Invitrogen™) and DAPI (4',6-diamidino-2-phenylindole) (Sigma Aldrich) to image F-actin and cell nuclei of cells on the surface or within hydrogels crosslinked by visible light after 1, 4, and 7 days of seeding. For staining, cells were fixed in 4% (v/v) paraformaldehyde in DPBS (Sigma Aldrich) for 15 min, permeabilized in 0.1% (w/v) Triton X-100 (Sigma Aldrich) for 5 min, and then blocked in 1% (w/v) bovine serum albumin (BSA, Sigma Aldrich) for 30 min. F-actin was then stained using Alexa fluor-488 phalloidin or Alexa fluor-594 phalloidin (1:40 dilution) in 0.1% bovine serum albumin (BSA) in DPBS for 45 min. After F-actin staining, cells were incubated in 1 μL/mL DAPI in DPBS for 5 min to stain cell nuclei. Quantitative analysis of cell densities and cell spreading after 1, 4, and 7 days of seeding was performed using fluorescence images acquired using an inverted fluorescence microscope (Zeiss Axio Observer Z1). Cell density in 2D cultures was quantified using the number of DAPIstained nuclei per given area. Cell spreading was quantified using positively stained F-actin per given area.
Immunostaining for cardiac markers:
The expression of the cardiomyocyte marker sarcomeric α-actinin was analyzed by immunofluorescent staining after 7 days of 2D seeding following previously established protocols 11 . Briefly, cells on the gel were fixed in 4% paraformaldehyde for 1 h at room temperature and washed with DPBS, then permeabilized in 0.1 %(w/v) Triton X-100 for 30 min, followed by blocking in 10 %(v/v) goat serum in PBS containing 0.1 % Triton x-100 for 1 h. Then, the cells were incubated with the primary antibody mouse-anti-sarcomeric α-actinin diluted 1:200 ratio in goat serum (10 %(v/v)) overnight at 4 °C, with subsequent washing steps with DPBS. The samples were then incubated for 2 h at room temperature with the secondary antibody (Alexa Fluor 594 goat-anti-mouse) diluted in goat serum (10 %(v/v), 1:200 ratio). After several washing steps with DPBS, the samples were stained with DAPI (1/1000 diluted in DPBS) for 5 min at room temperature. The stained gels were imaged using an inverted fluorescence microscope (Zeiss Axio Observer Z1) after washing 4 times with DPBS.
PrestoBlue assay: The metabolic activity of cells was measured on days 1, 3, and 5 using PrestoBlue assay (Life Technologies) according to the manufacturer's protocol. Briefly, samples were incubated with a solution containing 10% PrestoBlue reagent and 90% cell culture medium for an hour at 37 °C. The final fluorescence was measured using a BioTek UV/Vis Synergy HT microplate reader. The relative fluorescence values were calculated and reported for each day.
Ex vivo experiments:
All animal studies were conducted in accordance to Tufts University Guidelines and with IACUC approval. For ex vivo assessment of injectability into the myocardium, a male Sprague-Dawley rat (2+ months of age and 250-275 grams) was sacrificed via CO 2 asphyxiation followed by a thoracotomy. 200 μL of GelMA gel was injected into the free wall of the right ventricle and exposed to the visible light source for 180 sec (100 mW/m 2 ), at a distance of 1 cm. The deformation of the right ventricle by the presence of a solid gel below the epicardium was apparent. The whole heart was subsequently processed for histological analysis as described below.
In vivo GelMA prepolymer injection and crosslinking: Male, Sprague-Dawley rats (2+ months of age and 250-275 grams) were anesthetized with 4% isoflurane, and maintained at 2% during the surgery. Animals were intubated and received a thoracotomy between the 4 th and 5 th intercostal space. A retractor was placed between the ribs, the heart was exposed and an incision made within the pericardium. A 6-0 prolene suture was used to permanently occlude the left coronary artery such that blanching occurred across 40% of the left ventricular free wall, based on our previously described procedure 52 . For the animals receiving the GelMA hydrogel injection (n=3), 50 μL was delivered through a 25G needle to four distinct sites corresponding to the top center of the infarct, left most edge of the infarct, center of the infarct and right most edge. After a total of 200 μL was delivered, the visible light source was turned on and positioned 2 cm away from the surface of the heart for 180 sec, at a distance of 1 cm. Following light exposure, the lungs were fully inflated and the chest, muscle and skin were sutured closed. The animal was allowed to recover for 15 min under a heating lamp. The Sham animals received the same surgical procedure, but were injected with 0.9% pharmaceuticalgrade saline as opposed to the GelMA solution. Healthy animals did not undergo any surgical procedure, but were evaluated in the same manner as the other two experimental conditions. A total of 13 animals were used for the in vivo study with 2 healthy, 3 shams and 8 GelMA prepolymer injections. All animals survived the infarct and injection with no adverse events and were sacrificed 3 weeks after the surgery.
Heart isolation and histological assessment: Animals were sacrificed via CO 2 asphyxiation and hearts were isolated, fixed in 4% paraformaldehyde at 4 °C for 12 h and rinsed for 1 h, three times in 1X DPBS. Hearts were immersed in 30% sucrose for 12 h, embedded in Optimal Cutting Temperature compound (OCT) and flash frozen by submersion in methyl butane that was chilled by liquid nitrogen. The frozen hearts were sectioned into 10 µm slices with a Cryotome E Cryostat (Thermoscientific, Waltham, MA). Masson's Trichome stain (Sigma Aldrich) was performed to identify muscle (red) and collagen fibers (blue) following the manufacturer's protocol. Images were acquired with a Leica DFC340 FX microscope (Wetzlar, Germany). Additional sections were rinsed in 1X DPBS and permeation was performed with 0.5% triton-X 100 solution for 5 min followed by three rinses for 5 min in 1X PBS. Samples were blocked in a 1X PBS with 5% donkey serum and 1% BSA for 1 h at room temperature. Primary antibodies for Myosin Heavy Chain (sc-32732, 1:100), Cardiac α-Actin (sc-58670, 1:100), Smooth Muscle α-Actin (sc-32251, 1:200), and von Willebrand's Factor (Sigma F3520, 1:100) were diluted in 1% BSA. Cells were incubated in primary antibodies for 1 h at room temperature and then washed three times with 1X DPBS (incubation for 5 min each). Secondary antibodies (Alexa Fluor 488-conjucated donkey anti-rabbit A11008, Alexa Fluor 488-conjugated donkey-anti-goat A11055, and Alexa Fluor 555-conjugated donkey anti-mouse A31570) were diluted at 1:400 in 1% BSA in PBS. Cells were incubated with secondary antibodies with a 1:1,000 dilution of Hoechst fluorescent dye for 1 h at room temperature. Then, samples were washed in DPBS (3 x 5 min) and then imaged with an Olympus IX 81 fluorescent microscope.
Statistical analysis. Data were analyzed with one-way or two-way ANOVA followed by Tukey's post-hoc test (GraphPad Prism® 6.0c). Error bars represent the mean ± standard deviation (SD) of measurements (*p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001). . Effect of (g) VC and (h) TEA concentrations on the average pore sizes measured from SEM images. Error bars represent the SD of measurements on 3 different positions in 3 independent SEM images of each hydrogel (*p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001). The effect of (i) VC (1 %(w/v) TEA) and (j) TEA concentration (1 %(w/v) VC) on swelling ratio of GelMA gels produced by using 10% GelMA and 0.1 Mm Eosin Y. 
